Vulvar cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In 2012, the [[incidence]] of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The [[incidence]] of vulvar cancer increases with age, the median age at diagnosis is 68 years and it is more prevalent in the white race. | In 2012, the [[incidence]] of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The [[incidence]] of vulvar cancer increases with age, the median age at diagnosis is 68 years and it is more prevalent in the white race. | ||
==Epidemiology and Demographics== | |||
==Incidence== | ==Incidence== | ||
The [[incidence]] of vulvar cancer was 2.4 per 100,000 females in the United States. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | The [[incidence]] of vulvar cancer was 2.4 per 100,000 females in the United States. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | ||
==Age== | ==Age== | ||
*The [[incidence]] of vulvar cancer increases with age, the median age at diagnosis is 68 years.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | *The [[incidence]] of vulvar cancer increases with age, the median age at diagnosis is 68 years.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| Line 17: | Line 15: | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |6.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |15.3% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |22.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |14.9% | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |6.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |15.3% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |19.8% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |22.1% ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |14.9% | ||
|} | |} | ||
==Race== | ==Race== | ||
* Vulvar cancer is more prevalent in the white race.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | * Vulvar cancer is more prevalent in the white race.<ref> SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref> | ||
| Line 26: | Line 23: | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.5 per 100,000 | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.5 per 100,000 | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
Revision as of 19:44, 1 October 2015
|
Vulvar cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vulvar cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics |
|
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
In 2012, the incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age, the median age at diagnosis is 68 years and it is more prevalent in the white race.
Epidemiology and Demographics
Incidence
The incidence of vulvar cancer was 2.4 per 100,000 females in the United States. These rates are age-adjusted and based on 2008-2012 cases and deaths.[1]
Age
| Age | <20 | 20-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75-84 | >85 |
| Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
Race
- Vulvar cancer is more prevalent in the white race.[3]
| Race | All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | Non-Hispanic |
| Incidence | 2.4 per 100,000 | 2.6 per 100,000 | 1.8 per 100,000 | 0.9 per 100,000 | 2.0 per 100,000 | 1.7 per 100,000 | 2.5 per 100,000 |
References
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015
- ↑ SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015